ZA872120B - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
ZA872120B
ZA872120B ZA872120A ZA872120A ZA872120B ZA 872120 B ZA872120 B ZA 872120B ZA 872120 A ZA872120 A ZA 872120A ZA 872120 A ZA872120 A ZA 872120A ZA 872120 B ZA872120 B ZA 872120B
Authority
ZA
South Africa
Prior art keywords
compositions
treatment
infections
pharmaceutical composition
pessaries
Prior art date
Application number
ZA872120A
Other languages
English (en)
Inventor
Linda Mary Edwards
Mary Edwards Linda
Original Assignee
Smith & Nephew Ass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith & Nephew Ass filed Critical Smith & Nephew Ass
Publication of ZA872120B publication Critical patent/ZA872120B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA872120A 1986-03-22 1987-03-23 Pharmaceutical composition ZA872120B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868607159A GB8607159D0 (en) 1986-03-22 1986-03-22 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ZA872120B true ZA872120B (en) 1987-10-28

Family

ID=10595080

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA872120A ZA872120B (en) 1986-03-22 1987-03-23 Pharmaceutical composition

Country Status (10)

Country Link
US (1) US4803066A (xx)
EP (1) EP0241175B1 (xx)
JP (1) JPS62252725A (xx)
AT (1) ATE59297T1 (xx)
AU (1) AU590060B2 (xx)
CA (1) CA1280366C (xx)
DE (1) DE3767003D1 (xx)
ES (1) ES2038659T3 (xx)
GB (1) GB8607159D0 (xx)
ZA (1) ZA872120B (xx)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
JPH0818983B2 (ja) * 1987-12-08 1996-02-28 塩野義製薬株式会社 水虫治療剤
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
CA1337279C (en) * 1989-06-06 1995-10-10 Robert J. Borgman Intravaginal treatment of vaginal infections with buffered metronidazole compositions
NZ250363A (en) * 1992-12-04 1996-11-26 Susanna Elizabeth Chalmers A topical dressing containing a dessicant and an antimicrobial or antiseptic agent
US5370876A (en) * 1993-01-08 1994-12-06 Microbarriers Antimicrobial protective skin composition and method for protecting skin from body fluids
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
HU215443B (hu) 1994-07-25 1999-04-28 Márton Milánkovits Többféle hatóanyagot tartalmazó gyógyszerkészítmények, főként hüvelykúp, baktericid, fungicid, protozoa- és vírusellenes kombinált hatással
US6060604A (en) * 1995-03-31 2000-05-09 Florida State University Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
JP2002514220A (ja) 1997-05-12 2002-05-14 セイジ、ファーマスーティカルズ、インク 熱傷処置および感染防止のための局部スプレー
US6224896B1 (en) 1997-07-28 2001-05-01 Curlor Healthcare Technologies, Llc Composition and process for the treatment of epidermal traumas such as decubitus ulcers
US20030147925A1 (en) * 1998-09-11 2003-08-07 Samuel P. Sawan Topical dermal antimicrobial compositions, methods for generating same, and monitoring methods utilizing same
US6582683B2 (en) 2000-01-04 2003-06-24 Skinvisible Pharmaceuticals, Inc. Dermal barrier composition
US7137968B1 (en) 2000-03-13 2006-11-21 Nucryst Pharmaceuticals Corp. Transcutaneous medical device dressings and method of use
EP1267795A1 (en) * 2000-03-30 2003-01-02 Brennen Medical Inc. Anti-microbial and immunostimulating composition
US6719987B2 (en) 2000-04-17 2004-04-13 Nucryst Pharmaceuticals Corp. Antimicrobial bioabsorbable materials
US7008647B2 (en) * 2001-04-23 2006-03-07 Nucryst Pharmaceuticals Corp. Treatment of acne
US7427416B2 (en) * 2000-07-27 2008-09-23 Nucryst Pharmaceuticals Corp. Methods of treating conditions using metal-containing materials
US20030206966A1 (en) * 2000-07-27 2003-11-06 Burrell Robert E. Methods of inducing apoptosis and modulating metalloproteinases
US6989157B2 (en) * 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
US20030180379A1 (en) * 2000-07-27 2003-09-25 Burrell Robert E. Solutions and aerosols of metal-containing compounds
US7255881B2 (en) * 2000-07-27 2007-08-14 Nucryst Pharmaceuticals Corp. Metal-containing materials
US20040191329A1 (en) * 2000-07-27 2004-09-30 Burrell Robert E. Compositions and methods of metal-containing materials
US20030185901A1 (en) 2000-07-27 2003-10-02 Burrell Robert E. Methods of treating conditions with a metal-containing material
US6692773B2 (en) 2000-07-27 2004-02-17 Nucryst Pharmaceuticals Corp. Treatment of hyperproliferative skin disorders and diseases
US20030021854A1 (en) 2001-04-23 2003-01-30 Burrell Robert Edward Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US7001617B2 (en) 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US6399092B1 (en) 2000-12-27 2002-06-04 Healthpoint, Ltd. Anhydrous, hydrophilic absorbent wound dressing (tube) with antimicrobials or other pharmaceutically active agents
US6756059B2 (en) * 2001-08-20 2004-06-29 Skinvisible Pharmaceuticals, Inc. Topical composition, topical composition precursor, and methods for manufacturing and using
US7201925B2 (en) * 2002-04-23 2007-04-10 Nueryst Pharmaceuticals Corp. Treatment of ungual and subungual diseases
EP1567101A4 (en) * 2002-10-22 2009-06-03 Nucryst Pharm Corp METHODS OF PROPHYLACTIC TREATMENT
US20040126339A1 (en) * 2002-12-31 2004-07-01 Roszell James A. Sunscreen composition and methods for manufacturing and using a sunscreen composition
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
WO2005027807A1 (en) * 2003-09-19 2005-03-31 Drugtech Corporation Pharmaceutical delivery system
US20050214364A1 (en) * 2004-03-23 2005-09-29 Hutman Herbert W Products and methods for treating vaginal infections
JP2008540534A (ja) * 2005-05-09 2008-11-20 ドラッグテック コーポレイション 放出調節薬学組成物
AU2006250763A1 (en) 2005-05-27 2006-11-30 Bharat Biotech International Limited Epidermal growth factor composition, a process therefor and its application
JP2009522360A (ja) * 2006-01-05 2009-06-11 ドラッグテック コーポレイション 組成物およびその使用方法
EA200870155A1 (ru) * 2006-01-05 2009-02-27 Драгтек Корпорейшн Система доставки лекарственного средства
AU2007269440A1 (en) * 2006-06-30 2008-01-10 Nucryst Pharmaceuticals Corp. Metal-containing formulations and methods of use
US20100137333A1 (en) * 2006-10-20 2010-06-03 Roszell James A Antifungal composition and methods for using
US8128913B1 (en) 2007-12-06 2012-03-06 Skinvisible Pharmaceuticals, Inc. Sunscreen composition with enhanced UV-A absorber stability and methods
US8865227B2 (en) * 2007-12-20 2014-10-21 Smith & Nephew (Overseas) Limited Metal carbonate particles and methods of making thereof
US8299122B2 (en) * 2008-04-14 2012-10-30 Skinvisible Pharmaceuticals, Inc. Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition
FR2978664B1 (fr) 2011-08-04 2014-01-10 Petcare Innovation Composition antiseptique
US10335390B2 (en) 2014-09-05 2019-07-02 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis
PL411078A1 (pl) * 2015-01-27 2016-08-01 Uniwersytet Medyczny w Łodzi Związek kompleksowy srebra, sposób wytwarzania związku kompleksowego oraz zastosowanie związku kompleksowego
CA3074150A1 (en) 2020-02-18 2021-08-18 Ovation Science, Inc. Composition and method for transdermal delivery of cannabidiol (cbd) and delta9-tetrahydrocannabinol (thc)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2319852A1 (de) * 1972-04-21 1973-10-25 Biological Concepts Inc Verfahren zur herstellung einer zur aufnahme von arzneimitteln geeigneten, saugfaehigen fasermasse aus protein, insbesondere aus kollagen
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
EP0067671B1 (en) * 1981-06-12 1989-11-15 National Research Development Corporation Hydrogels
FR2558058B1 (fr) * 1984-01-18 1987-03-20 Pf Medicament Compositions dermatologiques a usage topique externe, a base de metronidazole utiles pour le traitement de l'acne
US4636520A (en) * 1984-07-16 1987-01-13 Fujisawa Pharmaceutical Co., Ltd. Antifungal composition employing pyrrolnitrin in combination with an imidazole compound

Also Published As

Publication number Publication date
EP0241175A1 (en) 1987-10-14
CA1280366C (en) 1991-02-19
EP0241175B1 (en) 1990-12-27
GB8607159D0 (en) 1986-04-30
ATE59297T1 (de) 1991-01-15
AU590060B2 (en) 1989-10-26
US4803066A (en) 1989-02-07
ES2038659T3 (es) 1993-08-01
DE3767003D1 (de) 1991-02-07
JPS62252725A (ja) 1987-11-04
AU7054387A (en) 1987-09-24

Similar Documents

Publication Publication Date Title
GB8607159D0 (en) Pharmaceutical composition
CA2148928A1 (en) Pharmacologically active pyridine derivatives and processes for the preparation thereof
AU6194694A (en) Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments
AU2745700A (en) A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
AU563748B2 (en) Quinolone carboxylic acids
MY102101A (en) Pharmaceutical gel composition
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
CA2274074A1 (en) Novel compounds with analgesic effect
CA2211389A1 (en) Novel pharmaceutical combination
CA2328368A1 (en) Anti-inflammatory agents
AU6194794A (en) Tetrazole derivatives of bile acids, processes for their preparation and the use of these compounds as medicaments
IE863104L (en) Quinolone derivatives
AU531878B2 (en) Medicated animal feed based on liver meal
AU1890295A (en) Piperidines and pyrrolidines
EP0249194A3 (en) Topical prostaglandin formulations
AU4445089A (en) Lactamimides in the treatment of drug-resistant protozoal infections
AU2861389A (en) Disubstituted pyridines
ZA979647B (en) Heterocyclic compounds, compositions and uses.
AU3435189A (en) Topically applied gold organic complex
CA2003213A1 (en) Antimycotically active cyclopropyl-substituted azolylmethylcarbinols
AU6608994A (en) Compositions for the treatment of inflammatory proliferative skin disease and their use
AU559768B2 (en) Aluminium or zinc panthenolate and their use for treating wounds
ZA979650B (en) Heterocyclic compounds, compositions and uses.
IE810891L (en) Topical formulation
AU7655494A (en) Treatment of laminitis